Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Exact Sciences Corp before investing.

In this article, we go over a few key elements for understanding Exact Sciences Corp’s stock price such as:

• Exact Sciences Corp’s current stock price and volume
• Why Exact Sciences Corp’s stock price changed recently
• Upgrades and downgrades for EXAS from analysts
• EXAS’s stock price momentum as measured by its relative strength

About Exact Sciences Corp (EXAS)

Before we jump into Exact Sciences Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Company’s flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Want to learn more about Exact Sciences Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Exact Sciences Corp.

Exact Sciences Corp’s Stock Price as of Market Close

As of June 20, 2024, 4:00 PM, CST, Exact Sciences Corp’s stock price was $44.00.

Exact Sciences Corp is up 4.96% from its previous closing price of $41.92.

During the last market session, Exact Sciences Corp’s stock traded between $41.33 and $42.54. Currently, there are 182.35 million shares of Exact Sciences Corp stock available for purchase.

Unfortunately, Exact Sciences Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Exact Sciences Corp Stock Price History

Exact Sciences Corp’s (EXAS) price is currently down 3.19% so far this month.

During the month of June, Exact Sciences Corp’s stock price has reached a high of $47.19 and a low of $41.08.

Over the last year, Exact Sciences Corp has hit prices as high as $100.77 and as low as $41.08. Year to date, Exact Sciences Corp’s stock is down 11.13%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Exact Sciences Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 18, 2024, there were 13 analysts who downgraded Exact Sciences Corp’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Exact Sciences Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Exact Sciences Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Exact Sciences Corp’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Exact Sciences Corp (EXAS) by visiting AAII Stock Evaluator.

Relative Price Strength of Exact Sciences Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 18, 2024, Exact Sciences Corp has a weighted four-quarter relative price strength of -25.05%, which translates to a Momentum Score of 14 and is considered to be Very Weak.

Want to learn more about how Exact Sciences Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Exact Sciences Corp Stock Price: Bottom Line

As of June 20, 2024, Exact Sciences Corp’s stock price is $44.00, which is up 4.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Exact Sciences Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.